Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people*
- 1 May 2004
- journal article
- Published by Wiley in HIV Medicine
- Vol. 5 (3), 144-150
- https://doi.org/10.1111/j.1468-1293.2004.00202.x
Abstract
To study the impact of hepatitis C virus (HCV) status on serum cholesterol levels in HIV-infected patients. We retrospectively analysed data from the 881 participants of the Veterans Ageing Cohort 3 Site Study. Four different models were constructed using total cholesterol, low-density lipid (LDL) cholesterol, high-density lipid (HDL) cholesterol and triglycerides as dependent variables. The relevant covariates included HCV antibody status, HIV medication class, CD4 count, HIV viral load, glucose level, lipid-lowering drug use, gender, race, age, liver function test results, ethanol use, drug use, and HIV exposure category. Variables excluded from the final model included niacin use, gender, race, age, current ethanol use, and HIV exposure category. Of the 881 HIV-positive patients enrolled in the study, 700 (79%) were screened for HCV antibody, with 300 (42.8%) HCV antibody positive and 400 (57.2%) HCV antibody negative. A positive HCV antibody status was independently associated with lower total cholesterol levels (P=0.001) and LDL cholesterol levels (P<0.001) but not with lower HDL cholesterol or triglyceride levels. HCV-positive patients had predicted LDL levels 19 mg/dL lower than those of HCV-negative subjects. HCV infection was also associated with a decreased use of lipid-lowering medication, and protease inhibitor use was associated with increased LDL and total cholesterol levels. HCV infection has been associated with lower cholesterol levels in HIV-negative individuals, and the same appears to be true with HIV-infected patients. This is an interesting finding given that HCV particles bind to LDL receptors in vitro and also because HCV-lipid interactions appear to be important in the HCV replication cycle.Keywords
This publication has 23 references indexed in Scilit:
- Effect of Highly Active Antiretroviral Therapy (HAART) and Hepatitis C Co-Infection on Hyperlipidemia in HIV-Infected Patients: A Retrospective Longitudinal StudyHIV Research & Clinical Practice, 2002
- Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing ParticlesJournal of Virology, 2002
- Long?Term Metabolic Consequences of Switching from Protease Inhibitors to Efavirenz in Therapy for Human Immunodeficiency Virus–Infected Patients with LipoatrophyClinical Infectious Diseases, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Effect of Coexisting HIV-1 Infection on the Diagnosis and Evaluation of Hepatitis C VirusJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Prognostic Value of Progressive Decrease in Serum Cholesterol in Predicting Survival in Child-Pugh C Viral CirrhosisScandinavian Journal of Gastroenterology, 1998
- Visualization of hepatitis C virions and putative defective interfering particles isolated from low‐density lipoproteinsJournal of Viral Hepatitis, 1996
- Plasma lipids in HIV‐infected patients: a prospective study in 95 patientsEuropean Journal of Clinical Investigation, 1994
- Hypocholesterolemia is associated to chronic hepatitis CHepatology, 1993
- Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndromeJournal of Clinical Endocrinology & Metabolism, 1992